Perigon Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,570
| Closed | -$305K | – | 1011 |
|
|
2024
Q2 | $305K | Buy |
2,570
+177
| +7% | +$21K | 0.01% | 680 |
|
|
2024
Q1 | $255K | Buy |
+2,393
| New | +$255K | 0.01% | 726 |
|
|
2023
Q4 | – | Sell |
-2,220
| Closed | -$229K | – | 858 |
|
|
2023
Q3 | $229K | Sell |
2,220
-190
| -8% | -$19.6K | 0.01% | 690 |
|
|
2023
Q2 | $293K | Sell |
2,410
-25
| -1% | -$3.04K | 0.01% | 618 |
|
|
2023
Q1 | $374K | Buy |
2,435
+36
| +2% | +$5.53K | 0.02% | 465 |
|
|
2022
Q4 | $431K | Sell |
2,399
-2,081
| -46% | -$374K | 0.03% | 418 |
|
|
2022
Q3 | $530K | Sell |
4,480
-2,652
| -37% | -$314K | 0.05% | 321 |
|
|
2022
Q2 | $1.02M | Buy |
7,132
+479
| +7% | +$68.4K | 0.09% | 205 |
|
|
2022
Q1 | $1.15M | Buy |
6,653
+5,236
| +370% | +$902K | 0.08% | 209 |
|
|
2021
Q4 | $360K | Buy |
1,417
+58
| +4% | +$14.7K | 0.03% | 412 |
|
|
2021
Q3 | $523K | Buy |
1,359
+204
| +18% | +$78.5K | 0.05% | 296 |
|
|
2021
Q2 | $271K | Buy |
+1,155
| New | +$271K | 0.02% | 424 |
|
|
2021
Q1 | – | Sell |
-879
| Closed | -$92K | – | 819 |
|
|
2020
Q4 | $92K | Buy |
+879
| New | +$92K | 0.01% | 559 |
|